MALLORY CALLINS: Open Payments
NPI 1629700802 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 28 payments from 12 companies in 2025. Trend: 2023 $422 · 2024 $410 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $168 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $49 |
| Exact Sciences Corporation | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| ABBVIE INC. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: PREVNAR 20, JARDIANCE, NURTEC ODT, AIRSUPRA, UBRELVY, BREZTRI, LEQVIO, Kerendia.
Industry payments across OK — which companies pay providers there.
